3 hospitalisations_par_moisAu Cameroun, la fréquence des hospitalisations pour drépanocytose est estimée à entre 3 et 4 par mois chez les enfants de moins de 5 ans.
CameroundrépanocytoseHAL · Unilimdocument of 75 observations
Explore evidence
Gold tier: mechanically validated evidence, with its primary source.
72 evidence items · page 1 / 3
349 cases349 out of 612 sickle cell disease patients had extracardiac organ damages including stroke, leg ulcer, priapism, microalbuminuria or osteonecrosis in Cameroon, Mali, and Senegal.
Cameroun · Mali · SénégaldrépanocytoseHAL · Unilimdocument of 2 observations
0.4 %The RHCE*04 (*CE) allelic background was found in 1 out of 216 total alleles (0.4%) among Cameroonian patients with sickle cell disease (SCD).
CameroundrépanocytoseHAL · Unilimdocument of 45 observations
20 %Dans des pays tels que le Cameroun, la République du Congo, le Gabon, le Ghana et le Nigeria, la prévalence de la drépanocytose est de 20 à 30 %.
Cameroun · Gabon · Ghana · NigeriadrépanocytoseHAL · Unilimdocument of 857 observations
The co-inheritance of a 3.7-kb α-globin gene deletion and SCD was associated with a late disease onset and possibly improved survival.
Cameroundrépanocytosepublished 2015Public health genomicseurope_pmcdocument of 6 observations
610 patientsIn 610 Cameroonian SCD patients, the genomic variations in two principal foetal haemoglobin-promoting loci were significantly associated with foetal haemoglobin levels.
Cameroundrépanocytosepublished 2015Public health genomicseurope_pmcdocument of 6 observations
2,583 individualsThe study included 2583 SCD patients and healthy controls aged 5–21 years old in Mali, Senegal, Cameroon, Gabon and the Ivory Coast.
Cameroun · Côte d'Ivoire · Gabon · Mali · Sénégaldrépanocytosepublished 2019British journal of haematologyeurope_pmcdocument of 6 observations
Body mass index (BMI), systolic blood pressure, vaso-occlusive crisis (VOC), and haemoglobin (Hb) explain kidney phenotypic variations in Cameroonian patients with sickle cell disease.
Cameroundrépanocytosepublished 2021Frontiers in geneticseurope_pmcdocument of 5 observations
3,627 patientsThe CADRE study included 3627 patients with sickle cell disease and 943 healthy controls.
Cameroun · Côte d'Ivoire · Gabon · Mali · Sénégaldrépanocytosepublished 2016CirculationPubMeddocument of 5 observations
22 patientsAmong 109 Cameroonian patients with sickle cell disease (SCD), 22 patients harbored two variant alleles at either the homozygous or compound heterozygous state and were considered to be expressing a variant (i.e., weak and/or partial) D phenotype.
CameroundrépanocytoseHAL · Unilimdocument of 45 observations
0.5 fractionOne patient in two failed to achieve a two-fold increase in cortisol levels after stimulation among sickle cell disease patients.
Cameroundrépanocytosepublished 2018The Pan African medical journaleurope_pmcdocument of 4 observations
3,699 patientsThe study involved 3699 sickle cell disease patients living in Mali, Senegal, Ivory Coast, Democratic Republic of Congo, Gabon and Cameroon.
Cameroun · Côte d'Ivoire · Gabon · Mali · Sénégaldrépanocytosepublished 2024British journal of haematologyeurope_pmcdocument of 10 observations
5 hospitalisations_par_moisAu Cameroun, la fréquence des hospitalisations pour drépanocytose est estimée à entre 5 et 7 hospitalisations par mois chez les adolescents.
CameroundrépanocytoseHAL · Unilimdocument of 75 observations
60.9 %Among 413 Sickle Cell Disease patients from Cameroon, 60.9% (n = 248) presented with micro-albuminuria.
Cameroundrépanocytosepublished 2017British journal of haematologyeurope_pmcdocument of 3 observations
10 patientsPartial RH2 antigen may be expected in 10 patients.
CameroundrépanocytoseHAL · Unilimdocument of 45 observations
133 percent_incrementThe percent increment of cortisol after stimulation was 133 in sickle cell disease patients.
Cameroundrépanocytosepublished 2018The Pan African medical journaleurope_pmcdocument of 4 observations
22 patientsAmong 109 Cameroonian patients with sickle cell disease (SCD), 22 patients harbored two variant alleles at either the homozygous or compound heterozygous state and were considered to be expressing a variant (i.e. weak and/or partial) D phenotype.
Cameroundrépanocytoseobserved 2023HAL · Unilimdocument of 45 observations
8.3 %The RHCE*03 (*cE) allelic background was found in 18 out of 216 total alleles (8.3%) among Cameroonian patients with sickle cell disease (SCD).
CameroundrépanocytoseHAL · Unilimdocument of 45 observations
2,000 professionnelsLe programme de formation de la Fondation Pierre Fabre vise plus de 2 000 professionnels (médecins, infirmiers, sages-femmes) et 3 000 étudiants en Côte d’Ivoire, en République Démocratique du Congo, en Centrafrique et au Cameroun.
Cameroun · RDCdrépanocytoseHAL · Unilimdocument of 857 observations
20 patientsPartial RH5 antigen may be expected in 20 patients.
CameroundrépanocytoseHAL · Unilimdocument of 45 observations
21 patientsPartial RH1 antigen may be expected in 21 patients.
CameroundrépanocytoseHAL · Unilimdocument of 45 observations
1 patientRH59 (CEAG) high-frequency antigen is thought to be defective in one patient.
CameroundrépanocytoseHAL · Unilimdocument of 45 observations
2.4 %Among 413 Cameroonian patients with sickle cell disease, 2.4% had proteinuria.
Cameroundrépanocytosepublished 2021Frontiers in geneticseurope_pmcdocument of 5 observations
2,407 patientsIn Mali, Cameroon, and Ivory Coast, 2407 sickle cell disease patients aged 3 years old and over were included in the study.
Cameroun · Côte d'Ivoire · Malidrépanocytosepublished 2017Bloodeurope_pmcdocument of 4 observationsDOI 10.1182/blood-2016-12-755777
61 %Among 413 Cameroonian patients with sickle cell disease, 61% had micro-albuminuria.
Cameroundrépanocytosepublished 2021Frontiers in geneticseurope_pmcdocument of 5 observations
1 / 3next →
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.